Leadership
Anupama D S has joined Dr. Reddy’s Laboratories as Head – Risk Management and Compliance for its Biologics Quality unit, effective November 2026. She brings nearly 20 years of experience across biopharmaceutical research, biosimilars, quality management, regulatory affairs and global program management.
Before joining Dr. Reddy’s, Anupama spent over six years at Biocon and Biocon Biologics, where she held several leadership positions. Most recently, she served as Head of Operations PMO (Senior Director), following her role as Head of Quality PMO (Associate Director). Her earlier responsibilities included global program management, regulatory affairs and managing the insulin portfolio, including the Viatris collaboration.
She began her career at Biocon in 2006 as a Scientist, progressing through roles including Senior Scientist, Principal Scientist and Associate Scientific Manager. Her technical experience includes analytical method development for proteins and HPLC method development for biosimilars.
In her new role, Anupama will oversee risk management and compliance across the Biologics Quality unit, focusing on Quality Management Systems, cGMP compliance, regulatory inspections and ensuring manufacturing sites meet global quality requirements.
CXO TechBOT congratulates Anupama D S on her new leadership appointment at Dr. Reddy’s Laboratories and wishes her success in this role.